1 Other diagnostic considerations, such as
pityriasis alba, pityriasis versicolor, and progressive
2 s lymphoproliferative diseases in childhood:
pityriasis lichenoides and cutaneous T-cell lymphoma.
3 is article will summarize recent articles on
pityriasis lichenoides and pediatric cutaneous T-cell ly
4 Pityriasis lichenoides has traditionally been divided in
5 Two cases of
pityriasis lichenoides were also studied.
6 le to recognize the clinical presentation of
pityriasis lichenoides, to understand the overlap betwee
7 Pityriasis rosea can present in a variety of manners.
8 Whereas
pityriasis rosea is a benign condition, it is important
9 Pityriasis rosea is a common skin condition seen in chil
10 Pityriasis rosea is a common skin disease that has been
11 These results suggest that
pityriasis rosea is associated with systemic active infe
12 Pityriasis rosea is self-limiting, usually lasting 1-3 m
13 copy failed to reveal herpesviral virions in
pityriasis rosea lesional skin.
14 Pityriasis rosea may lead to undesirable outcomes when a
15 , serum, and saliva samples isolated from 14
pityriasis rosea patients.
16 ar and periappendageal areas in 100% and 75%
pityriasis rosea skin lesions, respectively, compared to
17 to consider in the differential diagnosis of
pityriasis rosea.
18 be warranted for other conditions that mimic
pityriasis rosea.
19 nd other tissues isolated from patients with
pityriasis rosea.
20 ip to other exanthemas and eruptions such as
pityriasis rosea.
21 papular purpuric gloves and socks syndrome;
pityriasis rosea; unilateral lateral thoracic exanthem;
22 Pityriasis rubra pilaris (PRP) is a rare inflammatory sk
23 Pityriasis rubra pilaris (PRP) is a rare papulosquamous
24 Pityriasis rubra pilaris (PRP) is an inflammatory papulo
25 Treatment of
pityriasis rubra pilaris (PRP) is solely based on its re
26 Pityriasis rubra pilaris (PRP) refers to a group of eryt
27 d Drug Administration-approved treatment for
pityriasis rubra pilaris (PRP), and it is common for pat
28 amilial forms of psoriasis vulgaris (PV) and
pityriasis rubra pilaris (PRP).
29 Pityriasis rubra pilaris remains a challenging diagnosis
30 throdermic patients with Sezary syndrome and
pityriasis rubra pilaris, and healthy controls.
31 the inflammatory skin diseases psoriasis and
pityriasis rubra pilaris.
32 tic considerations, such as pityriasis alba,
pityriasis versicolor, and progressive macular hypomelan
33 ciated with several chronic diseases such as
pityriasis versicolor, folliculitis, and seborrheic derm
34 cutaneous lupus erythematosus, capillaritis,
pityriasis versicolor, nummular eczema, and cutaneous T-